1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hormonal Therapy
1.4.3 Chemotherapy
1.4.4 Immunotherapy
1.4.5 Targeted Therapy
1.5 Market by Application
1.5.1 Global Prostate Cancer Drugs Market Share by Application: 2021-2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Prostate Cancer Drugs Market
1.8.1 Global Prostate Cancer Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Prostate Cancer Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Prostate Cancer Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Prostate Cancer Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Prostate Cancer Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Prostate Cancer Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Prostate Cancer Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Prostate Cancer Drugs Sales Volume
3.3.1 North America Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Prostate Cancer Drugs Sales Volume
3.4.1 East Asia Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Prostate Cancer Drugs Sales Volume (2015-2020)
3.5.1 Europe Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Prostate Cancer Drugs Sales Volume (2015-2020)
3.6.1 South Asia Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Prostate Cancer Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Prostate Cancer Drugs Sales Volume (2015-2020)
3.8.1 Middle East Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Prostate Cancer Drugs Sales Volume (2015-2020)
3.9.1 Africa Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Prostate Cancer Drugs Sales Volume (2015-2020)
3.10.1 Oceania Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Prostate Cancer Drugs Sales Volume (2015-2020)
3.11.1 South America Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Prostate Cancer Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Prostate Cancer Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Prostate Cancer Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Prostate Cancer Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Prostate Cancer Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Prostate Cancer Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Prostate Cancer Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Prostate Cancer Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Prostate Cancer Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Prostate Cancer Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Prostate Cancer Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Prostate Cancer Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Prostate Cancer Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Prostate Cancer Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Prostate Cancer Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Prostate Cancer Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Prostate Cancer Drugs Consumption Volume by Application (2015-2020)
15.2 Global Prostate Cancer Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Prostate Cancer Drugs Business
16.1 AbbVie
16.1.1 AbbVie Company Profile
16.1.2 AbbVie Prostate Cancer Drugs Product Specification
16.1.3 AbbVie Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Novartis
16.2.1 Novartis Company Profile
16.2.2 Novartis Prostate Cancer Drugs Product Specification
16.2.3 Novartis Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson & Johnson
16.3.1 Johnson & Johnson Company Profile
16.3.2 Johnson & Johnson Prostate Cancer Drugs Product Specification
16.3.3 Johnson & Johnson Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Astellas Pharma
16.4.1 Astellas Pharma Company Profile
16.4.2 Astellas Pharma Prostate Cancer Drugs Product Specification
16.4.3 Astellas Pharma Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Merck Group
16.5.1 Merck Group Company Profile
16.5.2 Merck Group Prostate Cancer Drugs Product Specification
16.5.3 Merck Group Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Astra Zeneca
16.6.1 Astra Zeneca Company Profile
16.6.2 Astra Zeneca Prostate Cancer Drugs Product Specification
16.6.3 Astra Zeneca Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Bayer HealthCare
16.7.1 Bayer HealthCare Company Profile
16.7.2 Bayer HealthCare Prostate Cancer Drugs Product Specification
16.7.3 Bayer HealthCare Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 GlaxoSmithKline
16.8.1 GlaxoSmithKline Company Profile
16.8.2 GlaxoSmithKline Prostate Cancer Drugs Product Specification
16.8.3 GlaxoSmithKline Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Sanofi
16.9.1 Sanofi Company Profile
16.9.2 Sanofi Prostate Cancer Drugs Product Specification
16.9.3 Sanofi Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Amgen
16.10.1 Amgen Company Profile
16.10.2 Amgen Prostate Cancer Drugs Product Specification
16.10.3 Amgen Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Takeda Pharmaceuticals
16.11.1 Takeda Pharmaceuticals Company Profile
16.11.2 Takeda Pharmaceuticals Prostate Cancer Drugs Product Specification
16.11.3 Takeda Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Boehringer Ingelheim
16.12.1 Boehringer Ingelheim Company Profile
16.12.2 Boehringer Ingelheim Prostate Cancer Drugs Product Specification
16.12.3 Boehringer Ingelheim Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Ferring Pharmaceutical
16.13.1 Ferring Pharmaceutical Company Profile
16.13.2 Ferring Pharmaceutical Prostate Cancer Drugs Product Specification
16.13.3 Ferring Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Tokai Pharmaceuticals
16.14.1 Tokai Pharmaceuticals Company Profile
16.14.2 Tokai Pharmaceuticals Prostate Cancer Drugs Product Specification
16.14.3 Tokai Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Northwest Biotherapeutics
16.15.1 Northwest Biotherapeutics Company Profile
16.15.2 Northwest Biotherapeutics Prostate Cancer Drugs Product Specification
16.15.3 Northwest Biotherapeutics Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 BMS
16.16.1 BMS Company Profile
16.16.2 BMS Prostate Cancer Drugs Product Specification
16.16.3 BMS Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Janssen Pharmaceuticals
16.17.1 Janssen Pharmaceuticals Company Profile
16.17.2 Janssen Pharmaceuticals Prostate Cancer Drugs Product Specification
16.17.3 Janssen Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Foresee Pharmaceuticals
16.18.1 Foresee Pharmaceuticals Company Profile
16.18.2 Foresee Pharmaceuticals Prostate Cancer Drugs Product Specification
16.18.3 Foresee Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Teva Pharmaceutical
16.19.1 Teva Pharmaceutical Company Profile
16.19.2 Teva Pharmaceutical Prostate Cancer Drugs Product Specification
16.19.3 Teva Pharmaceutical Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Endo Pharmaceuticals
16.20.1 Endo Pharmaceuticals Company Profile
16.20.2 Endo Pharmaceuticals Prostate Cancer Drugs Product Specification
16.20.3 Endo Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.21 Spectrum Pharmaceuticals
16.21.1 Spectrum Pharmaceuticals Company Profile
16.21.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Specification
16.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Prostate Cancer Drugs Manufacturing Cost Analysis
17.1 Prostate Cancer Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Prostate Cancer Drugs
17.4 Prostate Cancer Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Prostate Cancer Drugs Distributors List
18.3 Prostate Cancer Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Prostate Cancer Drugs (2021-2026)
20.2 Global Forecasted Revenue of Prostate Cancer Drugs (2021-2026)
20.3 Global Forecasted Price of Prostate Cancer Drugs (2015-2026)
20.4 Global Forecasted Production of Prostate Cancer Drugs by Region (2021-2026)
20.4.1 North America Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Prostate Cancer Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Prostate Cancer Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Prostate Cancer Drugs by Country
21.2 East Asia Market Forecasted Consumption of Prostate Cancer Drugs by Country
21.3 Europe Market Forecasted Consumption of Prostate Cancer Drugs by Countriy
21.4 South Asia Forecasted Consumption of Prostate Cancer Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Prostate Cancer Drugs by Country
21.6 Middle East Forecasted Consumption of Prostate Cancer Drugs by Country
21.7 Africa Forecasted Consumption of Prostate Cancer Drugs by Country
21.8 Oceania Forecasted Consumption of Prostate Cancer Drugs by Country
21.9 South America Forecasted Consumption of Prostate Cancer Drugs by Country
21.10 Rest of the world Forecasted Consumption of Prostate Cancer Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer